4.2 Review

Sphingosine 1-Phosphate in Renal Diseases

Journal

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Volume 31, Issue 6, Pages 745-760

Publisher

KARGER
DOI: 10.1159/000350093

Keywords

Sphingosine 1-phosphate; Kidney disease; Diabetic nephropathy; Glomerulonephritis; Ischemia-reperfusion injury; Wilms tumor

Funding

  1. German Research Foundation [FOG784, KO3940/1-1, PF361/6-2, PF361/7-1, GRK1172, HU842/5-1]
  2. LOEWE Lipid Signaling Forschungszentrum Frankfurt
  3. Swiss National Science Foundation

Ask authors/readers for more resources

Because of its highly bioactive properties sphingosine 1-phosphate (S1P) is an attractive target for the treatment of several diseases. Since the expression of sphingosine kinases as well as S1P receptors was demonstrated in the kidney, questions about the physiological and pathophysiological functions of S1P in this organ have been raised. In this review, we summarize the current state of knowledge about S1P-mediated functions in the kidney. A special focus is put on S1P modulated signal transduction in renal glomerular and tubular cells and consequences for the development and treatment of several kidney diseases, diabetic nephropathy, glomerulonephritis, ischemia-reperfusion injury, as well as for Wilms tumor progression. Copyright (c) 2013 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available